UBS Group’s DataMeds AI, Inc. Common Stock MEDS Stock Holding History

UBS Group’s Portfolio MEDS Stock Details MEDS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-319	Closed	-$6.37K	–	11527
2025 Q4	$6.37K	Sell	319 -534	-63%	-$15.7K	﹤0.01%	8559
2025 Q3	$37.8K	Buy	+853	New	+$45K	﹤0.01%	7758
2025 Q2	–	Sell	-59	Closed	-$12.8K	–	11117
2025 Q1	$12.8K	Buy	+59	New	+$9.95K	﹤0.01%	8479

Other funds holding MEDS

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

ACT Advisors Asheville, North Carolina $301M AUM 23.36% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

UBS Group's MEDS Position: Q1 2026 in Review

UBS Group sold out of DataMeds AI, Inc. Common Stock (MEDS) in Q1 2026, closing a stake of 319 shares — an estimated $6.37K sold.

UBS Group first reported a position in MEDS in Q1 2025 and held it in 3 quarters. The position peaked at $37.8K in Q3 2025. 13 funds tracked by Wall St. Rank hold MEDS as of Q1 2026.

UBS Group reported no remaining DataMeds AI, Inc. Common Stock position as of Q1 2026 after selling out during the quarter.
UBS Group sold 319 DataMeds AI, Inc. Common Stock shares in Q1 2026, an estimated $6.37K.
UBS Group first reported a position in DataMeds AI, Inc. Common Stock in Q1 2025 and held it in 3 quarters.
UBS Group's DataMeds AI, Inc. Common Stock position peaked at $37.8K in Q3 2025.
13 funds tracked by Wall St. Rank held DataMeds AI, Inc. Common Stock as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.